Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices involving SelectQuote, Inc. following a lawsuit filed by the U.S. Department of Justice against the company and others in the health insurance sector [1][3]. Group 1: Investigation Details - Pomerantz LLP is representing investors of SelectQuote and is looking into whether the company and its officers engaged in illegal activities [1]. - The investigation is prompted by allegations that SelectQuote participated in a scheme involving illegal kickbacks related to Medicare Advantage plan enrollments [3]. Group 2: Legal Context - On May 1, 2025, the DOJ filed a False Claims Act complaint against SelectQuote and other insurers, claiming they paid hundreds of millions in illegal kickbacks from 2016 to 2021 [3]. - Following the announcement of the DOJ's lawsuit, SelectQuote's stock price dropped by $0.61, or 19.24%, closing at $2.56 per share [3]. Group 3: Firm Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of fighting for victims of securities fraud and corporate misconduct [4].

Financial Performance - Revenue increased by 8% year-over-year, reaching $408.2 million in 3Q25 compared to $376.4 million in 3Q24[14] - Adjusted EBITDA decreased to $37.7 million in 3Q25 from $46.6 million in 3Q24[14] - The combined Senior and Healthcare Services Revenue-to-Customer Acquisition Cost (Rev-to-CAC) multiple was 5.8x[14] - The company anticipates full year 2025 revenue between $1500 billion and $1575 billion, representing a 16% year-over-year increase at the midpoint[38] - The company anticipates full year 2025 Adjusted EBITDA between $115 million and $140 million, representing a 9% year-over-year increase at the midpoint[38] - The company anticipates full year 2025 Net Income (Loss) between $(1) million and $28 million, representing a 140% year-over-year increase at the midpoint[38] Senior Segment - Approved Medicare Advantage (MA) policies exceeded forecasts, despite a 26% reduction in the number of agents, resulting in only a 10% decrease in MA policies[14] - Strong close rates contributed to robust performance and Adjusted EBITDA margins of 27% in 3Q25[14,17] - Total approved policies decreased from 202,000 in 3Q24 to 186,000 in 3Q25[30] - Medicare Advantage Lifetime Value (MA LTV) decreased from $995 in 3Q24 to $915 in 3Q25[30] Healthcare Services (SelectRx) - SelectRx membership grew by 41% year-over-year, reaching nearly 106,000 members in 3Q25[14,22] - SelectRx generated nearly $675 million in trailing 12-month revenue[22]

Core Viewpoint - SelectQuote's stock price dropped over 19% following a lawsuit filed by the U.S. Department of Justice, alleging violations of the False Claims Act related to its business practices in the Medicare Advantage sector [1][3]. Company Investigation - Hagens Berman is investigating SelectQuote for potential misconduct regarding its sales practices and disclosures, particularly in its Senior business that offers Medicare Advantage plans [2][4]. - The investigation is focused on whether SelectQuote's claims of providing unbiased advice and comparison shopping for Medicare plans were misleading [3][4]. Allegations Against SelectQuote - The DOJ's complaint alleges that from 2016 to at least 2021, SelectQuote and other brokers received substantial payments from insurers for enrollments into Medicare Advantage plans, which may have influenced their sales practices [7]. - It is claimed that SelectQuote directed beneficiaries to plans that provided the highest kickbacks, rather than those that were most suitable for the beneficiaries [7]. - The company allegedly incentivized employees to prioritize plans based on kickbacks and discriminated against Medicare Advantage beneficiaries with disabilities [7].

Core Viewpoint - GoHealth, Inc. is under investigation for potential violations of federal securities laws and unlawful business practices following a False Claims Act complaint filed by the U.S. Department of Justice against several health insurance companies, including GoHealth [1][2]. Group 1: Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against GoHealth on behalf of its stockholders [1]. - The DOJ's complaint alleges that from 2016 to at least 2021, GoHealth and other insurers paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments into Medicare Advantage plans [2]. Group 2: Stock Market Impact - Following the announcement of the DOJ's lawsuit, GoHealth's stock price dropped by $1.09 per share, representing a decline of 10.35%, closing at $9.44 per share on May 1, 2025 [2].

Core Viewpoint - The Schall Law Firm is investigating SelectQuote, Inc. for potential violations of securities laws related to misleading statements and undisclosed information [1][2]. Investigation Details - The investigation centers on claims that SelectQuote may have issued false or misleading statements and failed to disclose critical information to investors [2]. - A DOJ False Claims Act was filed against SelectQuote on May 1, 2025, alleging that from 2016 to at least 2021, insurers paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [2]. - Following the news of the investigation, SelectQuote's shares dropped by 16% on the same day [2].

Core Viewpoint - SelectQuote's share price dropped over 19% following a lawsuit filed by the U.S. Department of Justice, alleging violations of the False Claims Act related to its business practices in the Medicare Advantage market [1][3]. Group 1: Lawsuit and Allegations - The U.S. Department of Justice filed a lawsuit against SelectQuote and other insurance brokers, claiming they violated the False Claims Act [1]. - The investigation focuses on SelectQuote's disclosures regarding its sales practices, particularly in its Senior business offering Medicare Advantage plans [2]. - Allegations include that SelectQuote directed Medicare beneficiaries to plans that provided the highest kickbacks to brokers, rather than acting in the best interest of the beneficiaries [5]. Group 2: Financial Impact - Following the announcement of the lawsuit, SelectQuote's shares fell by over 19% on May 1, 2025 [1][3]. - The lawsuit raises concerns about the potential inflation of SelectQuote's financial results due to alleged steering practices [4]. Group 3: Whistleblower Information - Whistleblowers with non-public information regarding SelectQuote are encouraged to assist in the investigation, with potential rewards of up to 30% of any successful recovery made by the SEC [4].

Core Viewpoint - Kirby McInerney LLP is investigating potential claims against GoHealth, Inc. regarding possible violations of federal securities laws and unlawful business practices [1] Group 1: Legal Investigation - The investigation focuses on whether GoHealth and/or its officers have engaged in unlawful business practices [1] - The U.S. Department of Justice filed a complaint against GoHealth, alleging that the company received illegal kickbacks from insurers for enrollments in Medicare Advantage plans [3] Group 2: Financial Impact - Following the DOJ complaint, GoHealth's share price dropped by $1.09, from $10.53 on April 30, 2025, to $9.44 on May 1, 2025 [3]

NEW YORK, May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of SelectQuote, Inc. ("SelectQuote" or the "Company") (NYSE: SLQT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether SelectQuote and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]On May 1, 2025, the U ...

NEW YORK, May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GoHealth, Inc. ("GoHealth" or the "Company") (NASDAQ: GOCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether GoHealth and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On May 1, 2025, the U.S. De ...

Core Viewpoint - The U.S. Department of Justice has filed a False Claims Act complaint against SelectQuote and other health insurance companies, alleging illegal kickbacks related to Medicare Advantage plans, leading to a significant drop in SelectQuote's stock price [2]. Group 1: Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against SelectQuote on behalf of its stockholders for possible violations of federal securities laws and unlawful business practices [1]. - The DOJ's complaint alleges that from 2016 to at least 2021, SelectQuote and other insurers paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [2]. Group 2: Stock Market Impact - Following the announcement of the DOJ lawsuit, SelectQuote's stock price decreased by $0.61 per share, representing a 19.24% decline, closing at $2.56 per share on May 1, 2025 [2].